Showing results (311-320 of 336) with videos related to

Sort By:
Pageof 34
Cell Cycle (Georgetown, Tex.)|May 2, 2018
Global expression profiling and pathway analysis of mouse mammary tumor reveals strain and stage specific dysregulated pathways in breast cancer progressionYan Mei, Jun-Ping Yang, Yan-Hong Lang, et al.
Ebiomedicine|April 11, 2025
Molecular heterogeneity of CD30+ peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyYu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Science Translational Medicine|February 4, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse modelsHailin Zhang, Yueshan Li, Yin Zhao, et al.
Cancer|January 4, 2026
Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohortThomas G Martin, María-Victoria Mateos, Jun Ho Yi, et al.
Nature|February 9, 2018
Evolutionary history of the angiosperm flora of ChinaLi-Min Lu, Ling-Feng Mao, Tuo Yang, et al.
Transplantation and Cellular Therapy|November 19, 2022
Hematopoietic Stem Cell Transplantation Activity in China 2020-2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry GroupLan-Ping Xu, Dao-Pei Lu, De-Pei Wu, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Romiplostim in primary immune thrombocytopenia that is persistent or chronic: phase III multicenter, randomized, placebo-controlled clinical trial in ChinaHu Zhou, Jianfeng Zhou, Depei Wu, et al.
World Journal of Pediatrics : WJP|December 9, 2023
Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: follow-up in a large CblC disease cohortSheng-Nan Wu, Hui-Shu E, Yue Yu, et al.
Blood Science (Baltimore, Md.)|September 3, 2025
China Expert consensus on the application of metagenomic next-generation sequencing for the etiological diagnosis of infections in hematological disorders (2024)Chunhui Xu, Ren Lin, Ye Bai, et al.
Experimental Hematology & Oncology|July 27, 2023
Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic eraTingting Zhang, Weiwei Tian, Shuang Wei, et al.
Pageof 34